OneDigital Investment Advisors’s Pacific Biosciences PACB Stock Holding History

OneDigital Investment Advisors’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,599	Closed	-$220K	–	774
2021 Q1	$220K	Sell	6,599 -1,351	-17%	-$47.3K	0.01%	593
2020 Q4	$206K	Buy	+7,950	New	+$135K	0.01%	593
2020 Q3	–	Sell	-10,341	Closed	-$36K	–	701
2020 Q2	$36K	Buy	+10,341	New	+$35.2K	﹤0.01%	607
2018 Q3	–	Sell	-25,559	Closed	-$91K	–	1149
2018 Q2	$91K	Buy	25,559 +2,199	+9%	+$6.1K	0.02%	357
2018 Q1	$48K	Buy	23,360 +4,296	+23%	+$11.2K	0.01%	536
2017 Q4	$50K	Buy	19,064 +6,902	+57%	+$24.2K	0.01%	513
2017 Q3	$64K	Buy	12,162 +1,463	+14%	+$6.29K	0.02%	322
2017 Q2	$38K	Buy	+10,699	New	+$43.1K	0.01%	554

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OneDigital Investment Advisors's PACB Position: Q2 2021 in Review

OneDigital Investment Advisors sold out of Pacific Biosciences (PACB) in Q2 2021, closing a stake of 6,599 shares — an estimated $220K sold.

OneDigital Investment Advisors first reported a position in PACB in Q2 2017 and held it in 8 quarters. The position peaked at $220K in Q1 2021. 262 funds tracked by Wall St. Rank hold PACB as of Q2 2021.

OneDigital Investment Advisors reported no remaining Pacific Biosciences position as of Q2 2021 after selling out during the quarter.
OneDigital Investment Advisors sold 6,599 Pacific Biosciences shares in Q2 2021, an estimated $220K.
OneDigital Investment Advisors first reported a position in Pacific Biosciences in Q2 2017 and held it in 8 quarters.
OneDigital Investment Advisors's Pacific Biosciences position peaked at $220K in Q1 2021.
262 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2021.

Based on OneDigital Investment Advisors's 13F filing for Q2 2021, filed 9 Aug 2021.